Viacheslav Nikolaev

Funded PhD opportunity in cardiovascular research at the University Medical Center Hamburg-Eppendorf (UKE) within the international DFG-funded Research Training Group (IRTG) 3215, “Microdomains in Cardiac Disease.” The programme is a German-French doctoral training network bringing together researchers from UKE and Université Paris-Saclay. It focuses on subcellular microdomains in cardiac disease and offers structured doctoral training in cardiovascular basic and translational research . Available projects cover topics such as cAMP/cGMP signaling , arrhythmias , heart failure , atrial fibrillation , cardiomyopathy , cardiomyocyte calcium handling , proteasome regulation , and mitochondrial dysfunction . Applicants may apply for up to three of the twelve research projects. The position is suitable for candidates with a Master’s, Diploma, or equivalent degree in biology, biochemistry, cell biology, physics, pharmacy, or related natural sciences . Medical graduates (MD / Dr. med.) may also apply. The post asks for excellent academic performance, prior research experience, very good English, strong motivation for cardiovascular research, and willingness to participate in research stays at the partner university. Funding is provided as a 65% E13 salary under the German public service pay scale. The programme also includes joint German-French supervision, transferable skills training, seminars, workshops, retreats, and mandatory research stays at the partner institution. Deadline: 2026-07-06. The programme starts on October 1, 2026 . How to apply: Submit a motivational letter naming the project(s) you want to join, a CV, Bachelor and Master transcripts, a recommendation letter, and immunity status documentation. Apply via the UKE job portal before the deadline.

University Medical Center Hamburg-Eppendorf is recruiting PhD candidates for the international DFG-funded Research Training Group (IRTG) 3215, “Microdomains in Cardiac Disease.” The programme is a German-French doctoral training environment focused on cardiovascular basic and translational research , with projects spanning cardiac signaling, electrophysiology, imaging, metabolism, arrhythmias, heart failure, and subcellular microdomains. Available projects include topics such as β1-adrenoceptor/cAMP microdomains, PDE3/PDE4 signaling, EPAC regulation, phospholamban function, RSK signaling, proteasome regulation, cGMP pools, gap junctions, mitochondrial dysfunction, endothelial regulation, mineralocorticoid receptor signaling, and intercalated disc biology. Doctoral candidates will be jointly supervised by researchers at University Medical Center Hamburg-Eppendorf and Université Paris-Saclay , with mandatory research stays at the partner institution in France. The programme starts on 2026-10-01 and runs for 3.5 years. For the first funding period, twelve PhD positions are available, and applicants may apply for up to three projects. The position is suitable for candidates with a Master’s, Diploma, or equivalent degree in biology, biochemistry, cell biology, physics, pharmacy, or related natural sciences; medical graduates (MD/Dr. med.) may also apply. Strong English skills, prior research experience, and a strong interest in cardiovascular research are emphasized. The role includes independent experimental work, use of advanced methods in biochemistry, cell biology, pharmacology, imaging, and functional techniques, plus participation in seminars, workshops, retreats, and methodological courses. Funding is provided through the DFG-funded graduate school, with the advertised position funded at 65% of a full-time E13 salary under the German public service pay scale. Applicants should submit a motivational letter naming the project(s), CV, transcripts, recommendation letter, and immunity documentation. The closing date listed on the job page is 2026-07-06 . Contact for the department: Prof. Dr. Viacheslav Nikolaev ( [email protected] ). For the RP5 project, contact [email protected] and [email protected] , or apply via the linked portal.